TrialEuropean journal of nuclear medicine and molecular imaging2020

A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma.

Jennifer E Gains et al.PubMed ↗Publisher ↗

No numbers read from the abstract.